They have shown that tumor cells primarily clustered according to a GEP-based clinical prognostic classifier, and can be divided into two groups: class 1 (BAP1 wild-type) and class 2 (BAP1 mutant) tumors [144]. This evidence concerns the gene BAP1 and neoplasm.